Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGETED TISSUE PERFUSION VERSUS MACROCIRCULATORY-GUIDED
2015-005112-15Phase 2Completed
- Sponsor
- Inselspital
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of norepinephrine in septic shock and sepsis (2 arms), sponsored by Inselspital. Primary endpoint: Days alive in 30 days with normal arterial blood lactate. Started Jun 2016; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shocksepsis
Beyond the preview
Go deeper on 2015-005112-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005112-15.